Skip to content

Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion

Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00855842
Acronym
DAIS
Enrollment
4
Registered
2009-03-04
Start date
2009-03-31
Completion date
2010-01-31
Last updated
2011-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Induced

Keywords

second trimester abortion, labor induction abortion, second trimester medical abortion, pregnancy

Brief summary

One the day prior to medical abortion (labor induction) in the second trimester, insertion of osmotic dilators is added to the routine procedures. The study is to see whether the addition of dilators decreases the abortion time (time for the pregnancy to be expelled)

Detailed description

This is a pilot study and is an uncontrolled, non-randomized series. Women having a medical abortion in second trimester undergo several procedures the day before the medication to cause contractions occurs. On the day before admission, they take mifepristone orally, and have a feticidal injection. to this would be added the insertion of cervical osmotic dilators (the intervention). On the day of induction, the dilators would be removed and misoprostol started to cause contractions. We are hoping the median abortion time will drop from the present 9-10 hours to 4-6 hours. women who do not abort in 6 hours will have option of surgical completion of the abortion (dilation and evacuation) if medically appropriate.

Interventions

osmotic dilators are placed in the cervix to cause cervical dilation

Sponsors

Boston University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Requesting abortion 19-23 weeks * No contraindication to induction abortion

Exclusion criteria

* Fetal demise * Ruptured membranes * Evidence of pelvic infection * Inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Length of Medical Abortionhours since the start of medical abortionThis is the time elapsed from the first dose of misoprostol (the agent to induce abortion) and expulsion of the fetus

Countries

United States

Participant flow

Recruitment details

Women requesting abortion at 19-23 weeks were eligible to enroll if they were able to consent and had no contraindications to medical abortion. Women were informed of the study after all counseling for abortion was completed and after they had given consent for abortion

Pre-assignment details

Women were eligible for study intervention if they had singleton pregnancy with intact membranes, without signs of infection.

Participants by arm

ArmCount
Osmotic Dilator
osmotic dilator
4
Total4

Baseline characteristics

CharacteristicOsmotic Dilator
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Age Continuous27 years
STANDARD_DEVIATION 5
Region of Enrollment
United States
4 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

Length of Medical Abortion

This is the time elapsed from the first dose of misoprostol (the agent to induce abortion) and expulsion of the fetus

Time frame: hours since the start of medical abortion

ArmMeasureValue (MEAN)Dispersion
Osmotic DilatorLength of Medical Abortion7 hoursStandard Deviation 5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026